BioSante Freed From 2 Investor Suits Over Libido Drug
In a pair of decisions, U.S. District Judge Joan B. Gottschall dismissed a shareholder class action over disappointing clinical results for the company's LibiGel testosterone gel treatment for women with low sex drive and a derivative complaint over the same events.
In the shareholder class action,...
Already a subscriber? Click here to login